Companies / Mabgenesis
Mabgenesis
Japan
MabGenesis provides first-in-class and best-in-class therapeutic monoclonal antibodies
Mabgenesis, based in Japan, has 3 investors on file, among them Beyond Next Ventures, Miyagin Venture Capital and SMBC Venture Capital. Its site was last checked 6 Nov 2026: site answers.
Investors
3 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Mabgenesis and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Beyond Next Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/mabgenesis.com/investors
# also
GET /v1/companies/mabgenesis.com
GET /v1/companies/mabgenesis.com/news